Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
![](/report_cover/2534/regenerative-medicine-market-global-industry-trends-share-size-growth-opportunity-n-forecast-2023-2028_en.gif)
Market Overview:
The global regenerative medicine market size reached US$ 18.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.4 Billion by 2028, exhibiting a growth rate (CAGR) of 22.4% during 2023-2028.
Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer’s, Parkinson’s and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.
The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, oncological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient. Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global regenerative medicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Stem Cell Therapy
Biomaterial
Tissue Engineering
Others
Breakup by Application:
Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others
Breakup by End User:
Hospitals
Specialty Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global regenerative medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global regenerative medicine market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global regenerative medicine market and who are the key players?
What is the degree of competition in the industry?
The global regenerative medicine market size reached US$ 18.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.4 Billion by 2028, exhibiting a growth rate (CAGR) of 22.4% during 2023-2028.
Regenerative medicine refers to a branch of biomedical sciences aimed at restoring the structure and function of damaged tissues and organs. It involves the utilization of stem cells that are developed in laboratories and further implanted safely into the body for the regeneration of damaged bones, cartilage, blood vessels and organs. Cellular and acellular regenerative medicines are commonly used in various clinical therapeutic procedures, including cell, immunomodulation and tissue engineering therapies. They hold potential for the effective treatment of various chronic diseases, such as Alzheimer’s, Parkinson’s and cardiovascular disorders (CVDs), osteoporosis and spinal cord injuries.
The increasing prevalence of chronic medical ailments and genetic disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is prone to various musculoskeletal, oncological, dermatological and cardiological disorders, is stimulating the market growth. In line with this, widespread adoption of organ transplantation is also contributing to the market growth. Regenerative medicine minimizes the risk of organ rejection by the body post-transplant and enhances the recovery speed of the patient. Additionally, various technological advancements in cell-based therapies, such as the development of 3D bioprinting techniques and the adoption of artificial intelligence (AI) in the production of regenerative medicines, are acting as other growth-inducing factors. These advancements also aid in conducting efficient dermatological grafting procedures to treat chronic burns, bone defects and wounds on the skin. Other factors, including extensive research and development (R&D) activities in the field of medical sciences, along with improving healthcare infrastructure, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global regenerative medicine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Stem Cell Therapy
Biomaterial
Tissue Engineering
Others
Breakup by Application:
Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Others
Breakup by End User:
Hospitals
Specialty Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Allergan PLC (AbbVie Inc.), Amgen Inc., Baxter International Inc., BD (Becton, Dickinson and Company), Integra Lifesciences Holdings Corporation, Medtronic plc, Mimedx Group Inc., Novartis AG, Osiris Therapeutics Inc. (Smith & Nephew plc) and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global regenerative medicine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global regenerative medicine market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global regenerative medicine market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL REGENERATIVE MEDICINE MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Stem Cell Therapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biomaterial
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Tissue Engineering
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Bone Graft Substitutes
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Osteoarticular Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Central Nervous System
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Specialty Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Allergan PLC (AbbVie Inc.)
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Baxter International Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 BD (Becton, Dickinson and Company)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Integra Lifesciences Holdings Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Medtronic Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Mimedx Group Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Thermo Fisher Scientific Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL REGENERATIVE MEDICINE MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY TYPE
6.1 Stem Cell Therapy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Biomaterial
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Tissue Engineering
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY APPLICATION
7.1 Bone Graft Substitutes
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Osteoarticular Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Cardiovascular
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Central Nervous System
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 MARKET BREAKUP BY END USER
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Specialty Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Allergan PLC (AbbVie Inc.)
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amgen Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Baxter International Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 BD (Becton, Dickinson and Company)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Integra Lifesciences Holdings Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Medtronic Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Mimedx Group Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Novartis AG
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Thermo Fisher Scientific Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Regenerative Medicine Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Regenerative Medicine Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Regenerative Medicine Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Regenerative Medicine Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Regenerative Medicine Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Regenerative Medicine Market Structure
Table 7: Global: Regenerative Medicine Market: Key Players
Table 1: Global: Regenerative Medicine Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Regenerative Medicine Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Regenerative Medicine Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Regenerative Medicine Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Regenerative Medicine Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Regenerative Medicine Market Structure
Table 7: Global: Regenerative Medicine Market: Key Players
LIST OF FIGURES
Figure 1: Global: Regenerative Medicine Market: Major Drivers and Challenges
Figure 2: Global: Regenerative Medicine Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Regenerative Medicine Market: Breakup by Type (in %), 2022
Figure 4: Global: Regenerative Medicine Market: Breakup by Application (in %), 2022
Figure 5: Global: Regenerative Medicine Market: Breakup by End User (in %), 2022
Figure 6: Global: Regenerative Medicine Market: Breakup by Region (in %), 2022
Figure 7: Global: Regenerative Medicine Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Regenerative Medicine (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Regenerative Medicine (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Regenerative Medicine (Biomaterial) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Regenerative Medicine (Biomaterial) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Regenerative Medicine (Tissue Engineering) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Regenerative Medicine (Tissue Engineering) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Regenerative Medicine (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Regenerative Medicine (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Regenerative Medicine (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Regenerative Medicine (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Regenerative Medicine (Osteoarticular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Regenerative Medicine (Osteoarticular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Regenerative Medicine (Dermatology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Regenerative Medicine (Dermatology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Regenerative Medicine (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Regenerative Medicine (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Regenerative Medicine (Central Nervous System) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Regenerative Medicine (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Regenerative Medicine (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Regenerative Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Regenerative Medicine (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Regenerative Medicine (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Regenerative Medicine (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Regenerative Medicine (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Regenerative Medicine (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Regenerative Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: North America: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: North America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: United States: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: United States: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Canada: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Canada: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Asia Pacific: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Asia Pacific: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: China: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: China: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Japan: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Japan: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: India: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: India: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: South Korea: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: South Korea: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Australia: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Australia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Indonesia: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Indonesia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Europe: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Europe: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Germany: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Germany: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: France: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: France: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: United Kingdom: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: United Kingdom: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Italy: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Italy: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Spain: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Spain: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Russia: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Russia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Latin America: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Latin America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Brazil: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Brazil: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Mexico: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Mexico: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Middle East and Africa: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Middle East and Africa: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Global: Regenerative Medicine Industry: SWOT Analysis
Figure 83: Global: Regenerative Medicine Industry: Value Chain Analysis
Figure 84: Global: Regenerative Medicine Industry: Porter’s Five Forces Analysis
Figure 1: Global: Regenerative Medicine Market: Major Drivers and Challenges
Figure 2: Global: Regenerative Medicine Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Regenerative Medicine Market: Breakup by Type (in %), 2022
Figure 4: Global: Regenerative Medicine Market: Breakup by Application (in %), 2022
Figure 5: Global: Regenerative Medicine Market: Breakup by End User (in %), 2022
Figure 6: Global: Regenerative Medicine Market: Breakup by Region (in %), 2022
Figure 7: Global: Regenerative Medicine Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 8: Global: Regenerative Medicine (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Regenerative Medicine (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Regenerative Medicine (Biomaterial) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Regenerative Medicine (Biomaterial) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Regenerative Medicine (Tissue Engineering) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Regenerative Medicine (Tissue Engineering) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Regenerative Medicine (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Regenerative Medicine (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Regenerative Medicine (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Regenerative Medicine (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Regenerative Medicine (Osteoarticular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Regenerative Medicine (Osteoarticular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Regenerative Medicine (Dermatology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Regenerative Medicine (Dermatology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Regenerative Medicine (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Regenerative Medicine (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Regenerative Medicine (Central Nervous System) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Regenerative Medicine (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Regenerative Medicine (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Regenerative Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Regenerative Medicine (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Regenerative Medicine (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Regenerative Medicine (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Regenerative Medicine (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Regenerative Medicine (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Regenerative Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: North America: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: North America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: United States: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: United States: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Canada: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Canada: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Asia Pacific: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Asia Pacific: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: China: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: China: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Japan: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Japan: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: India: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: India: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: South Korea: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: South Korea: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Australia: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Australia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Indonesia: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Indonesia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Europe: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Europe: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Germany: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Germany: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: France: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: France: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: United Kingdom: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: United Kingdom: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Italy: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Italy: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Spain: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Spain: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Russia: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Russia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Latin America: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Latin America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Brazil: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Brazil: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Mexico: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Mexico: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Middle East and Africa: Regenerative Medicine Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Middle East and Africa: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Global: Regenerative Medicine Industry: SWOT Analysis
Figure 83: Global: Regenerative Medicine Industry: Value Chain Analysis
Figure 84: Global: Regenerative Medicine Industry: Porter’s Five Forces Analysis